Maselli did not specify projected revenues, or comment on a question about a label expansion, but said that Catalent was projecting a 65% increase in revenue from its gene therapy customers in 2024
[4] GLP-1 Drugs: A Promising New Frontier for Cancer Risk Reduction (Accessed July August 2025)
"GoodRx Launches New $39/Month Weight Loss Telemedicine." 2025 investors.goodrx.com/news-releases/news-release-details/goodrx-launches-new-39-month-weight-loss-telemedicine U.S
However, these recommendations lack sufficient evaluation of the risk-benefit profile in HS-specific populations, thereby justifying further safety studies
CrossRef Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight Vitor Ferreira, Cintia Folgueira, Maria Guilln, Pablo Zubiaur, Marcos Navares, Assel Sarsenbayeva, Pilar Lpez-Larrubia, Jan W
Furthermore, research was published explaining how human plasma DSIP decreases at the point of sleep regardless of the timing of the sleep, i.e, a persons usual sleep time, or a later sleep time, natural DSIP still decreased